BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baumann CR, Mignot E, Lammers GJ, Overeem S, Arnulf I, Rye D, Dauvilliers Y, Honda M, Owens JA, Plazzi G, Scammell TE. Challenges in diagnosing narcolepsy without cataplexy: a consensus statement. Sleep 2014;37:1035-42. [PMID: 24882898 DOI: 10.5665/sleep.3756] [Cited by in Crossref: 92] [Cited by in F6Publishing: 72] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Kawai R, Watanabe A, Fujita S, Hirose M, Esaki Y, Arakawa C, Iwata N, Kitajima T. Utility of the sleep stage sequence preceding sleep onset REM periods for the diagnosis of narcolepsy: a study in a Japanese cohort. Sleep Med 2020;68:9-17. [PMID: 31999982 DOI: 10.1016/j.sleep.2019.04.008] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Tisdale RK, Yamanaka A, Kilduff TS. Animal models of narcolepsy and the hypocretin/orexin system: Past, present, and future. Sleep 2021;44:zsaa278. [PMID: 33313880 DOI: 10.1093/sleep/zsaa278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Fernandes GB, Cremaschi RC, Poyares D, Tufik S, Coelho FM. Prevalence of nocturnal sleep onset rapid movement sleep period (SOREMP) in narcolepsy type 1 and type 2. Sleep Med 2017;38:162-3. [PMID: 28889987 DOI: 10.1016/j.sleep.2017.08.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
4 Zhang Y, Ren R, Yang L, Zhang H, Shi Y, Vitiello MV, Tang X, Sanford LD. Comparative polysomnography parameters between narcolepsy type 1/type 2 and idiopathic hypersomnia: A systematic review and meta-analysis. Sleep Medicine Reviews 2022. [DOI: 10.1016/j.smrv.2022.101610] [Reference Citation Analysis]
5 Jacobson LH, Chen S, Mir S, Hoyer D. Orexin OX2 Receptor Antagonists as Sleep Aids. In: Lawrence AJ, de Lecea L, editors. Behavioral Neuroscience of Orexin/Hypocretin. Cham: Springer International Publishing; 2017. pp. 105-36. [DOI: 10.1007/7854_2016_47] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
6 Malter M, Neuneier J, Triller A, Kallweit U. [Narcolepsy in adults: Definition, etiology and treatment]. Fortschr Neurol Psychiatr 2021;89:103-13. [PMID: 33339064 DOI: 10.1055/a-1244-2612] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Tió E, Gaig C, Giner-soriano M, Romero O, Jurado M, Sansa G, Pujol M, Sans O, Álvarez-guerrico I, Caballol N, Jimenez M, Becerra J, Escartin A, Monasterio C, Molins A, Bove A, Viña J, Iranzo A, Cambrodi R, Calvo G, Morros R, Santamaria J. The prevalence of narcolepsy in Catalunya (Spain). J Sleep Res 2018;27:e12640. [DOI: 10.1111/jsr.12640] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
8 Lammers GJ, Bassetti CL, Dolenc-groselj L, Jennum PJ, Kallweit U, Khatami R, Lecendreux M, Manconi M, Mayer G, Partinen M, Plazzi G, Reading PJ, Santamaria J, Sonka K, Dauvilliers Y. Diagnosis of central disorders of hypersomnolence: A reappraisal by European experts. Sleep Medicine Reviews 2020;52:101306. [DOI: 10.1016/j.smrv.2020.101306] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 13.5] [Reference Citation Analysis]
9 Barateau L, Pizza F, Plazzi G, Dauvilliers Y. 50th anniversary of the ESRS in 2022-JSR special issue. J Sleep Res 2022;:e13631. [PMID: 35624073 DOI: 10.1111/jsr.13631] [Reference Citation Analysis]
10 Barateau L, Lopez R, Arnulf I, Lecendreux M, Franco P, Drouot X, Leu-semenescu S, Jaussent I, Dauvilliers Y. Comorbidity between central disorders of hypersomnolence and immune-based disorders. Neurology 2016;88:93-100. [DOI: 10.1212/wnl.0000000000003432] [Cited by in Crossref: 31] [Cited by in F6Publishing: 9] [Article Influence: 5.2] [Reference Citation Analysis]
11 Santiago JCP, Otto M, Kern W, Baier PC, Hallschmid M. Relationship between cerebrospinal fluid concentrations of orexin A/hypocretin-1 and body composition in humans. Peptides 2018;102:26-30. [PMID: 29471000 DOI: 10.1016/j.peptides.2018.02.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Plazzi G, Clawges HM, Owens JA. Clinical Characteristics and Burden of Illness in Pediatric Patients with Narcolepsy. Pediatric Neurology 2018;85:21-32. [DOI: 10.1016/j.pediatrneurol.2018.06.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
13 Postiglione E, Antelmi E, Pizza F, Lecendreux M, Dauvilliers Y, Plazzi G. The clinical spectrum of childhood narcolepsy. Sleep Medicine Reviews 2018;38:70-85. [DOI: 10.1016/j.smrv.2017.04.003] [Cited by in Crossref: 48] [Cited by in F6Publishing: 34] [Article Influence: 12.0] [Reference Citation Analysis]
14 Ruoff C, Rye D. The ICSD-3 and DSM-5 guidelines for diagnosing narcolepsy: clinical relevance and practicality. Current Medical Research and Opinion 2016;32:1611-22. [DOI: 10.1080/03007995.2016.1208643] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
15 Cairns A, Bogan R. Comparison of the macro and microstructure of sleep in a sample of sleep clinic hypersomnia cases. Neurobiol Sleep Circadian Rhythms 2019;6:62-9. [PMID: 31236521 DOI: 10.1016/j.nbscr.2019.02.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
16 Lopez R, Barateau L, Evangelista E, Dauvilliers Y. Depression and Hypersomnia: A Complex Association. Sleep Med Clin 2017;12:395-405. [PMID: 28778237 DOI: 10.1016/j.jsmc.2017.03.016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 4.2] [Reference Citation Analysis]
17 Miyagawa T, Hida A, Shimada M, Uehara C, Nishino Y, Kadotani H, Uchiyama M, Ebisawa T, Inoue Y, Kamei Y, Tokunaga K, Mishima K, Honda M. A missense variant in PER2 is associated with delayed sleep-wake phase disorder in a Japanese population. J Hum Genet 2019;64:1219-25. [PMID: 31527662 DOI: 10.1038/s10038-019-0665-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
18 Black J, Swick T, Bogan R, Lai C, Carter LP. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy. Sleep Medicine 2016;24:57-62. [DOI: 10.1016/j.sleep.2016.07.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
19 Dye TJ, Jain SV, Kothare SV. Central Hypersomnia. Semin Pediatr Neurol 2015;22:93-104. [PMID: 26072339 DOI: 10.1016/j.spen.2015.03.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
20 Torstensen EW, Pickering L, Kornum BR, Wanscher B, Baandrup L, Jennum PJ. Diagnostic value of actigraphy in hypersomnolence disorders. Sleep Med 2021;85:1-7. [PMID: 34265481 DOI: 10.1016/j.sleep.2021.06.033] [Reference Citation Analysis]
21 Lopez R, Micoulaud-Franchi JA, Camodeca L, Gachet M, Jaussent I, Dauvilliers Y. Association of Inattention, Hyperactivity, and Hypersomnolence in Two Clinic-Based Adult Cohorts. J Atten Disord 2020;24:555-64. [PMID: 29771183 DOI: 10.1177/1087054718775826] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
22 Abad VC. An evaluation of sodium oxybate as a treatment option for narcolepsy. Expert Opinion on Pharmacotherapy 2019;20:1189-99. [DOI: 10.1080/14656566.2019.1617273] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
23 Khan Z, Trotti LM. Central Disorders of Hypersomnolence: Focus on the Narcolepsies and Idiopathic Hypersomnia. Chest 2015;148:262-73. [PMID: 26149554 DOI: 10.1378/chest.14-1304] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 5.4] [Reference Citation Analysis]
24 Weng HH, Chen CF, Tsai YH, Wu CY, Lee M, Lin YC, Yang CT, Tsai YH, Yang CY. Gray matter atrophy in narcolepsy: An activation likelihood estimation meta-analysis. Neurosci Biobehav Rev 2015;59:53-63. [PMID: 25825285 DOI: 10.1016/j.neubiorev.2015.03.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
25 Lopez R, Doukkali A, Barateau L, Evangelista E, Chenini S, Jaussent I, Dauvilliers Y. Test–Retest Reliability of the Multiple Sleep Latency Test in Central Disorders of Hypersomnolence. Sleep 2017;40. [DOI: 10.1093/sleep/zsx164] [Cited by in Crossref: 48] [Cited by in F6Publishing: 31] [Article Influence: 9.6] [Reference Citation Analysis]
26 Pérez-Carbonell L, Leschziner G. Clinical update on central hypersomnias. J Thorac Dis 2018;10:S112-23. [PMID: 29445535 DOI: 10.21037/jtd.2017.10.161] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
27 Zhang J, Han F. Sleepiness in Narcolepsy. Sleep Medicine Clinics 2017;12:323-30. [DOI: 10.1016/j.jsmc.2017.03.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
28 Khatami R, Luca G, Baumann CR, Bassetti CL, Bruni O, Canellas F, Dauvilliers Y, Del Rio-villegas R, Feketeova E, Ferri R, Geisler P, Högl B, Jennum P, Kornum BR, Lecendreux M, Martins-da-silva A, Mathis J, Mayer G, Paiva T, Partinen M, Peraita-adrados R, Plazzi G, Santamaria J, Sonka K, Riha R, Tafti M, Wierzbicka A, Young P, Lammers GJ, Overeem S; European Narcolepsy Network. The European Narcolepsy Network (EU-NN) database. J Sleep Res 2016;25:356-64. [DOI: 10.1111/jsr.12374] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
29 Peyron C, Seugnet L, Lin JS. Commentary: A Quest for a Novel Peripheral Biomarker for Narcolepsy. CNS Neurosci Ther 2015;21:681-2. [PMID: 26281778 DOI: 10.1111/cns.12433] [Reference Citation Analysis]
30 Barateau L, Lopez R, Dauvilliers Y. Clinical neurophysiology of CNS hypersomnias. Handb Clin Neurol 2019;161:353-67. [PMID: 31307613 DOI: 10.1016/B978-0-444-64142-7.00060-6] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
31 Cairns A, Bogan R. Prevalence and Clinical Correlates of a Short Onset REM Period (SOREMP) during Routine PSG. Sleep 2015;38:1575-81. [PMID: 26039966 DOI: 10.5665/sleep.5050] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
32 Postiglione E, Barateau L, Pizza F, Lopez R, Antelmi E, Rassu AL, Vandi S, Chenini S, Mignot E, Dauvilliers Y, Plazzi G. Narcolepsy with intermediate cerebrospinal level of hypocretin-1. Sleep 2021:zsab285. [PMID: 34902030 DOI: 10.1093/sleep/zsab285] [Reference Citation Analysis]
33 Bhattarai J, Sumerall S. Current and Future Treatment Options for Narcolepsy: A Review. Sleep Sci 2017;10:19-27. [PMID: 28966734 DOI: 10.5935/1984-0063.20170004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
34 Taddei RN, Werth E, Poryazova R, Baumann CR, Valko PO. Diagnostic delay in narcolepsy type 1: combining the patients' and the doctors' perspectives. J Sleep Res 2016;25:709-15. [DOI: 10.1111/jsr.12420] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
35 Gauci S, Hosking W, Bruck D, Schumacher U. Narcolepsy, cataplexy, hypocretin and co-existing other health complaints: A review. Cogent Medicine 2017;4:1312791. [DOI: 10.1080/2331205x.2017.1312791] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
36 Lopez R, Barateau L, Evangelista E, Chenini S, Robert P, Jaussent I, Dauvilliers Y. Temporal Changes in the Cerebrospinal Fluid Level of Hypocretin-1 and Histamine in Narcolepsy. Sleep 2017;40. [PMID: 28364477 DOI: 10.1093/sleep/zsw010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
37 Franceschini C, Pizza F, Antelmi E, Folli MC, Plazzi G. Narcolepsy treatment: pharmacological and behavioral strategies in adults and children. Sleep Breath 2020;24:615-27. [PMID: 31290083 DOI: 10.1007/s11325-019-01894-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
38 Reiter J, Katz E, Scammell TE, Maski K. Usefulness of a Nocturnal SOREMP for Diagnosing Narcolepsy with Cataplexy in a Pediatric Population. Sleep 2015;38:859-65. [PMID: 25325489 DOI: 10.5665/sleep.4728] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 0.1] [Reference Citation Analysis]
39 Kim LJ, Coelho FM, Hirotsu C, Araujo P, Bittencourt L, Tufik S, Andersen ML. Frequencies and Associations of Narcolepsy-Related Symptoms: A Cross-Sectional Study. J Clin Sleep Med 2015;11:1377-84. [PMID: 26235160 DOI: 10.5664/jcsm.5268] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
40 Thorpy M, Morse AM. Reducing the Clinical and Socioeconomic Burden of Narcolepsy by Earlier Diagnosis and Effective Treatment. Sleep Medicine Clinics 2017;12:61-71. [DOI: 10.1016/j.jsmc.2016.10.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
41 Evangelista E, Lopez R, Barateau L, Chenini S, Bosco A, Jaussent I, Dauvilliers Y. Alternative diagnostic criteria for idiopathic hypersomnia: A 32-hour protocol: Idiopathic Hypersomnia. Ann Neurol 2018;83:235-47. [DOI: 10.1002/ana.25141] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
42 Abad VC, Guilleminault C. New developments in the management of narcolepsy. Nat Sci Sleep 2017;9:39-57. [PMID: 28424564 DOI: 10.2147/NSS.S103467] [Cited by in Crossref: 47] [Cited by in F6Publishing: 13] [Article Influence: 9.4] [Reference Citation Analysis]
43 Black SW, Sun JD, Santiago P, Laihsu A, Kimura N, Yamanaka A, Bersot R, Humphries PS. Partial ablation of the orexin field induces a sub-narcoleptic phenotype in a conditional mouse model of orexin neurodegeneration. Sleep 2018;41. [DOI: 10.1093/sleep/zsy116] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
44 Bozluolcay M, Nalbantoglu M, Benbir Senel G, Karadeniz D. What Does One Sleep-Onset REM Period—During Either Nocturnal Polysomnography or Multiple Sleep Latency Test—Mean in Differential Diagnosis of Central Hypersomnias? J Clin Neurophysiol 2015;32:364-8. [PMID: 26241245 DOI: 10.1097/WNP.0000000000000192] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
45 Clasadonte J, Scemes E, Wang Z, Boison D, Haydon PG. Connexin 43-Mediated Astroglial Metabolic Networks Contribute to the Regulation of the Sleep-Wake Cycle. Neuron 2017;95:1365-1380.e5. [PMID: 28867552 DOI: 10.1016/j.neuron.2017.08.022] [Cited by in Crossref: 76] [Cited by in F6Publishing: 73] [Article Influence: 15.2] [Reference Citation Analysis]
46 Maski K, Trotti LM, Kotagal S, Robert Auger R, Swick TJ, Rowley JA, Hashmi SD, Watson NF. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. J Clin Sleep Med 2021;17:1895-945. [PMID: 34743790 DOI: 10.5664/jcsm.9326] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
47 Ito W, Honda M, Ueno T, Kato N. Hypersomnia with ADHD: a possible subtype of narcolepsy type 2. Sleep Biol Rhythms. [DOI: 10.1007/s41105-017-0139-1] [Reference Citation Analysis]
48 Miyagawa T, Tokunaga K. Genetics of narcolepsy. Hum Genome Var 2019;6:4. [PMID: 30652006 DOI: 10.1038/s41439-018-0033-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
49 Monaca C, Franco P, Philip P, Dauvilliers Y. French consensus. Type 1 and type 2 Narcolepsy: Investigations and follow-up. Revue Neurologique 2017;173:25-31. [DOI: 10.1016/j.neurol.2016.09.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
50 Kretzschmar U, Werth E, Sturzenegger C, Khatami R, Bassetti CL, Baumann CR. Which diagnostic findings in disorders with excessive daytime sleepiness are really helpful? A retrospective study. J Sleep Res 2016;25:307-13. [PMID: 26864219 DOI: 10.1111/jsr.12383] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
51 Saini P, Rye DB. Hypersomnia. Sleep Medicine Clinics 2017;12:47-60. [DOI: 10.1016/j.jsmc.2016.10.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
52 Baumann-Vogel H, Schreckenbauer L, Valko PO, Werth E, Baumann CR. Narcolepsy type 2: A rare, yet existing entity. J Sleep Res 2021;30:e13203. [PMID: 32989797 DOI: 10.1111/jsr.13203] [Reference Citation Analysis]
53 Zhang Z, Mayer G, Dauvilliers Y, Plazzi G, Pizza F, Fronczek R, Santamaria J, Partinen M, Overeem S, Peraita-Adrados R, da Silva AM, Sonka K, Rio-Villegas RD, Heinzer R, Wierzbicka A, Young P, Högl B, Bassetti CL, Manconi M, Feketeova E, Mathis J, Paiva T, Canellas F, Lecendreux M, Baumann CR, Barateau L, Pesenti C, Antelmi E, Gaig C, Iranzo A, Lillo-Triguero L, Medrano-Martínez P, Haba-Rubio J, Gorban C, Luca G, Lammers GJ, Khatami R. Exploring the clinical features of narcolepsy type 1 versus narcolepsy type 2 from European Narcolepsy Network database with machine learning. Sci Rep 2018;8:10628. [PMID: 30006563 DOI: 10.1038/s41598-018-28840-w] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
54 Krahn LE, Zee PC, Thorpy MJ. Current Understanding of Narcolepsy 1 and its Comorbidities: What Clinicians Need to Know. Adv Ther 2022;39:221-43. [PMID: 34894325 DOI: 10.1007/s12325-021-01992-4] [Reference Citation Analysis]
55 Latorre D, Kallweit U, Armentani E, Foglierini M, Mele F, Cassotta A, Jovic S, Jarrossay D, Mathis J, Zellini F, Becher B, Lanzavecchia A, Khatami R, Manconi M, Tafti M, Bassetti CL, Sallusto F. T cells in patients with narcolepsy target self-antigens of hypocretin neurons. Nature 2018;562:63-8. [DOI: 10.1038/s41586-018-0540-1] [Cited by in Crossref: 138] [Cited by in F6Publishing: 115] [Article Influence: 34.5] [Reference Citation Analysis]
56 Alomar M, Almeneessier AS, Olaish AH, Alshiban A, Alomar A, BaHammam AS. Immune-mediated comorbidities in Saudi patients with narcolepsy. Nat Sci Sleep 2019;11:35-43. [PMID: 31118849 DOI: 10.2147/NSS.S195650] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
57 Sakai N, Matsumura M, Lin L, Mignot E, Nishino S. HPLC analysis of CSF hypocretin-1 in type 1 and 2 narcolepsy. Sci Rep 2019;9:477. [PMID: 30679597 DOI: 10.1038/s41598-018-36942-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
58 Barateau L, Lopez R, Chenini S, Rassu A, Scholz S, Lotierzo M, Cristol J, Jaussent I, Dauvilliers Y. Association of CSF orexin-A levels and nocturnal sleep stability in patients with hypersomnolence. Neurology 2020;95:e2900-11. [DOI: 10.1212/wnl.0000000000010743] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
59 Franceschini C, Pizza F, Cavalli F, Plazzi G. A practical guide to the pharmacological and behavioral therapy of Narcolepsy. Neurotherapeutics 2021;18:6-19. [PMID: 33886090 DOI: 10.1007/s13311-021-01051-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Muza R, Lykouras D, Rees K. The utility of a 5(th) nap in multiple sleep latency test. J Thorac Dis 2016;8:282-6. [PMID: 26904269 DOI: 10.3978/j.issn.2072-1439.2015.12.66] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
61 Feketeova E, Tormasiova M, Klobučníková K, Durdik P, Jarcuskova D, Benca M, Vitkova M. Narcolepsy in Slovakia – Epidemiology, clinical and polysomnographic features, comorbid diagnoses: a case-control study. Sleep Medicine 2020;67:15-22. [DOI: 10.1016/j.sleep.2019.10.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
62 Mamelak M, Swick T, Emsellem H, Montplaisir J, Lai C, Black J. A 12-week open-label, multicenter study evaluating the safety and patient-reported efficacy of sodium oxybate in patients with narcolepsy and cataplexy. Sleep Medicine 2015;16:52-8. [DOI: 10.1016/j.sleep.2014.10.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
63 Bughin F, Desplan M, Mestejanot C, Picot MC, Roubille F, Jaffuel D, Mercier J, Jaussent I, Dauvilliers Y. Effects of an individualized exercise training program on severity markers of obstructive sleep apnea syndrome: a randomised controlled trial. Sleep Med 2020;70:33-42. [PMID: 32193052 DOI: 10.1016/j.sleep.2020.02.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Song J, Kim T, Kim SM, Um YH, Jeong J, Seo H, Oh JH, Hong SC. Nocturnal Sleep Onset Rapid Eye Movement Sleep Periods as a Predictor of the Severity of Narcolepsy in Korea. Sleep Med Res 2020;11:19-24. [DOI: 10.17241/smr.2019.00444] [Reference Citation Analysis]
65 Sunwoo J. Narcolepsy, autoimmunity, and influenza A H1N1 vaccination. encephalitis 2021;1:31-5. [DOI: 10.47936/encephalitis.2021.00010] [Reference Citation Analysis]
66 Barateau L, Lopez R, Dauvilliers Y. Treatment Options for Narcolepsy. CNS Drugs 2016;30:369-79. [PMID: 27155860 DOI: 10.1007/s40263-016-0337-4] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 11.6] [Reference Citation Analysis]
67 Dauvilliers Y, Evangelista E, Barateau L, Lopez R, Chenini S, Delbos C, Beziat S, Jaussent I. Measurement of symptoms in idiopathic hypersomnia: The Idiopathic Hypersomnia Severity Scale. Neurology 2019;92:e1754-62. [DOI: 10.1212/wnl.0000000000007264] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 3.7] [Reference Citation Analysis]
68 Barateau L, Jaussent I, Lopez R, Boutrel B, Leu-Semenescu S, Arnulf I, Dauvilliers Y. Smoking, Alcohol, Drug Use, Abuse and Dependence in Narcolepsy and Idiopathic Hypersomnia: A Case-Control Study. Sleep 2016;39:573-80. [PMID: 26564129 DOI: 10.5665/sleep.5530] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
69 Murer T, Imbach LL, Hackius M, Taddei RN, Werth E, Poryazova R, Gavrilov YV, Winkler S, Waldvogel D, Baumann CR, Valko PO. Optimizing MSLT Specificity in Narcolepsy With Cataplexy. Sleep 2017;40. [DOI: 10.1093/sleep/zsx173] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
70 Fronczek R, Arnulf I, Baumann CR, Maski K, Pizza F, Trotti LM. To split or to lump? Classifying the central disorders of hypersomnolence. Sleep 2020;43:zsaa044. [PMID: 32193539 DOI: 10.1093/sleep/zsaa044] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 14.0] [Reference Citation Analysis]
71 Lopez R, Arnulf I, Drouot X, Lecendreux M, Dauvilliers Y. French consensus. Management of patients with hypersomnia: Which strategy? Revue Neurologique 2017;173:8-18. [DOI: 10.1016/j.neurol.2016.09.018] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 4.4] [Reference Citation Analysis]
72 Maski KP, Colclasure A, Little E, Steinhart E, Scammell TE, Navidi W, Diniz Behn C. Stability of nocturnal wake and sleep stages defines central nervous system disorders of hypersomnolence. Sleep 2021;44:zsab021. [PMID: 33512510 DOI: 10.1093/sleep/zsab021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Cao MT, Guilleminault C. Narcolepsy. Principles and Practice of Sleep Medicine. Elsevier; 2017. pp. 873-882.e5. [DOI: 10.1016/b978-0-323-24288-2.00090-8] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
74 Bin-Hasan S, Videnovic A, Maski K. Nocturnal REM Sleep Without Atonia Is a Diagnostic Biomarker of Pediatric Narcolepsy. J Clin Sleep Med 2018;14:245-52. [PMID: 29351827 DOI: 10.5664/jcsm.6944] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
75 Yu YA. Pediatric Sleep Medicine Cases. Curr Sleep Med Rep 2022;:1-12. [PMID: 35345531 DOI: 10.1007/s40675-022-00223-8] [Reference Citation Analysis]
76 Kim T, Lee JH, Lee CS, Yoon IY. Different fates of excessive daytime sleepiness: survival analysis for remission. Acta Neurol Scand 2016;134:35-41. [PMID: 26392230 DOI: 10.1111/ane.12504] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
77 Barker EC, Flygare J, Paruthi S, Sharkey KM. Living with Narcolepsy: Current Management Strategies, Future Prospects, and Overlooked Real-Life Concerns. Nat Sci Sleep 2020;12:453-66. [PMID: 32765142 DOI: 10.2147/NSS.S162762] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
78 Lee RU, Radin JM. A population-based epidemiologic study of adult-onset narcolepsy incidence and associated risk factors, 2004-2013. J Neurol Sci 2016;370:29-34. [PMID: 27772778 DOI: 10.1016/j.jns.2016.08.026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
79 Maski K, Steinhart E, Williams D, Scammell T, Flygare J, McCleary K, Gow M. Listening to the Patient Voice in Narcolepsy: Diagnostic Delay, Disease Burden, and Treatment Efficacy. J Clin Sleep Med 2017;13:419-25. [PMID: 27923434 DOI: 10.5664/jcsm.6494] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 9.8] [Reference Citation Analysis]
80 Lima FCB, do Nascimento Junior EB, Teixeira SS, Coelho FM, Oliveira GDP. Thinking outside the box: cataplexy without narcolepsy. Sleep Med 2019;61:118-21. [PMID: 31427075 DOI: 10.1016/j.sleep.2019.03.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
81 El-Solh AA, Rudraraju A, Pasrija D, Bui H. Pharmacotherapy of residual excessive sleepiness among continuous positive airway pressure (CPAP) treated patients with sleep apnea. Expert Opin Pharmacother 2022;:1-10. [PMID: 35045769 DOI: 10.1080/14656566.2022.2029408] [Reference Citation Analysis]
82 Beattie L, Espie CA, Kyle SD, Biello SM. How are normal sleeping controls selected? A systematic review of cross-sectional insomnia studies and a standardized method to select healthy controls for sleep research. Sleep Med 2015;16:669-77. [PMID: 25953299 DOI: 10.1016/j.sleep.2015.01.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
83 Plante DT, Cook JD, Goldstein MR. Objective measures of sleep duration and continuity in major depressive disorder with comorbid hypersomnolence: a primary investigation with contiguous systematic review and meta-analysis. J Sleep Res 2017;26:255-65. [PMID: 28145043 DOI: 10.1111/jsr.12498] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
84 Black SW, Yamanaka A, Kilduff TS. Challenges in the development of therapeutics for narcolepsy. Prog Neurobiol 2017;152:89-113. [PMID: 26721620 DOI: 10.1016/j.pneurobio.2015.12.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
85 Dongol EM, Williams AJ. Residual excessive sleepiness in patients with obstructive sleep apnea on treatment with continuous positive airway pressure. Curr Opin Pulm Med 2016;22:589-94. [PMID: 27583668 DOI: 10.1097/MCP.0000000000000324] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]